Market Overview

Research and Markets: Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2012

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/j6mgzb/global_ovarian) has announced the addition of the "Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2012" report to their offering.

The report provides insights into Ovarian Cancer epidemiology, Ovarian Cancer diagnosed patients, and Ovarian Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Ovarian Cancer derived from epidemiological analysis, percentage of patients diagnosed with Ovarian Cancer, and percentage of patients treated with Ovarian Cancer therapy.

The study helps executives estimate Ovarian Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Ovarian Cancer prevalence, Ovarian Cancer diagnosis rate, and Ovarian Cancer treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:

- Ovarian Cancer: Disease Definition

- Ovarian Cancer Patient Flow

- Ovarian Cancer Prevalence

- Ovarian Cancer Diagnosed Patients

- Ovarian Cancer Treated Patients

For more information visit http://www.researchandmarkets.com/research/j6mgzb/global_ovarian

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

 

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free